Core Laboratories Inc. CLB
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.60% | 854.88% | -115.95% | -65.25% | 33.88% |
| Total Depreciation and Amortization | -2.64% | 1.62% | 2.62% | 2.06% | -2.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.03% | 74.89% | -79.12% | 290.63% | -85.97% |
| Change in Net Operating Assets | -43.35% | -550.90% | 91.48% | -86.83% | -343.89% |
| Cash from Operations | -36.37% | 96.95% | -50.10% | -6.54% | -38.94% |
| Capital Expenditure | 35.64% | -17.93% | -33.93% | -20.53% | 29.99% |
| Sale of Property, Plant, and Equipment | -95.58% | 6.17% | 123.20% | 339.47% | -84.27% |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 77.56% | 2,722.22% | 106.08% | -102.81% | 125.74% |
| Cash from Investing | 18.82% | -15.92% | 9.62% | -256.79% | 245.56% |
| Total Debt Issued | -6.67% | -77.27% | 450.00% | 9.09% | -8.33% |
| Total Debt Repaid | 0.00% | 74.80% | -287.50% | 20.00% | -66.67% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 60.91% | 32.67% | -50.49% | 46.98% | -82.88% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.22% | 0.00% | 1.29% | -0.22% | 0.85% |
| Other Financing Activities | 99.46% | -- | -- | 100.05% | -19,900.00% |
| Cash from Financing | 20.82% | -766.96% | 93.58% | 56.72% | -414.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,517.86% | -171.79% | 104.00% | 47.35% | -161.22% |